出版物 打印 Anderson JD, Voss MM, Laughlin BS, Garda AE, Aziz K, Mullikin TC, Haddock MG, Petersen IA, DeWees TA, Vora SA. Outcomes of Proton Beam Therapy Compared With Intensity-Modulated Radiation Therapy for Uterine Cancer. Int J Part Ther. 2023 Winter; 9 (3):10-17 Epub 2022 Nov 14 View PubMed Gao RW, Mullikin TC, Aziz KA, Afzal A, Smith NL, Routman DM, Gergelis KR, Harmsen WS, Remmes NB, Tseung HSWC, Shiraishi SS, Boughey JC, Ruddy KJ, Harless CA, Garda AE, Waddle MR, Park SS, Shumway DA, Corbin KS, Mutter RW. Postmastectomy Intensity Modulated Proton Therapy: 5-Year Oncologic and Patient-Reported Outcomes. Int J Radiat Oncol Biol Phys. 2023 Nov 15; 117 (4):846-856 Epub 2023 May 26 View PubMed Xu C, Garda AE, Kumar A. R0 Resection in Recurrent Gynecologic Malignancy: Pelvic Exenteration and Beyond. Curr Treat Options Oncol. 2023 Apr; 24 (4):262-273 Epub 2023 Feb 27 View PubMed Garda AE, Hunzeker AE, Michel AK, Fattahi S, Shiraishi S, Remmes NB, Schultz HL, Harmsen WS, Shumway DA, Yan ES, Park SS, Mutter RW, Corbin KS. Intensity Modulated Proton Therapy for Bilateral Breast or Chest Wall and Comprehensive Nodal Irradiation for Synchronous Bilateral Breast Cancer: Initial Clinical Experience and Dosimetric Comparison. Adv Radiat Oncol. 2022 May-Jun; 7 (3):100901 Epub 2022 Jan 24 View PubMed Jethwa KR, Day CN, Sandhyavenu H, Gonuguntla K, Harmsen WS, Breen WG, Routman DM, Garda AE, Hubbard JM, Halfdanarson TR, Neben-Wittich MA, Merrell KW, Hallemeier CL, Haddock MG. Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experience. Clin Transl Radiat Oncol. 2021 May; 28:17-23 Epub 2021 Feb 23 View PubMed Garda AE, Navin PJ, Merrell KW, Martenson JA, Neben Wittich MA, Haddock MG, Sio TT, Rule WG, Ashman JB, Sheedy SP, Hallemeier CL. Patterns of inguinal lymph node metastases in anal canal cancer and recommendations for elective clinical target volume (CTV) delineation. Radiother Oncol. 2020 Aug; 149:128-133 Epub 2020 May 15 View PubMed Jethwa KR, Jang S, Gonuguntla K, Garda AE, Evans JD, Whitaker TJ, Day CN, Haddock MG, Petersen IA. Lymph node-directed simultaneous integrated boost in patients with clinically lymph node-positive cervical cancer treated with definitive chemoradiotherapy: clinical outcomes and toxicity Journal of Radiation Oncology. 09 June 2020. Garda AE, Sheedy SP, Haddock MG, Hallemeier CL. Cystic Lymph Node Metastases From HPV-Associated Squamous Cell Carcinoma of the Anal Canal. Pract Radiat Oncol. 2020 Mar - Apr; 10 (2):e111-e115 Epub 2019 Dec 19 View PubMed Chen KS, Glaser SM, Garda AE, Vargo JA, Saiful Huq M, Heron DE, Beriwal S. Utilizing clinical pathways and web-based conferences to improve quality of care in a large integrated network using breast cancer radiation therapy as the model. Radiat Oncol. 2018 Mar 16; 13 (1):44 View PubMed Trifiletti DM, Hill C, Garda A, Kabadi S, Shah NR, Sheehan JP, Larner JM. Multi-lesion glioblastoma multiforme in the modern chemo-radiotherapy era: An analysis of pattern of failure and overall survival Journal of Radiation Oncology.2017;6:(1)57-63. Romano KD, Trifiletti DM, Garda A, Xu Z, Schlesinger D, Watkins WT, Neal B, Larner JM, Sheehan JP. Choosing a Prescription Isodose in Stereotactic Radiosurgery for Brain Metastases: Implications for Local Control. World Neurosurg. 2017 Feb; 98:761-767.e1. Epub 2016 Nov 17. View PubMed Trifiletti DM, Garda AE, Showalter TN. Implanted spacer approaches for pelvic radiation therapy. Expert Rev Med Devices. 2016 Jul; 13 (7):633-40 Epub 2016 June 09 View PubMed Trifiletti DM, Libby B, Feuerlein S, Kim T, Garda A, Watkins WT, Erickson S, Ornan A, Showalter TN. Implementing MRI-based target delineation for cervical cancer treatment within a rapid workflow environment for image-guided brachytherapy: A practical approach for centers without in-room MRI. Brachytherapy. 2015 Nov-Dec; 14 (6):905-9 Epub 2015 Aug 29 View PubMed PST-20519264 主页 出版物